Evidence map›Paper›PMID 36288385›Full record

ArticlePloS one2022

Efficiency of Malaysian states in managing the COVID-19 outbreak in 2020 and 2021.

Abdul Rahim Isnain, Nazri Che Dom, Samsuri Abdullah, Nopadol Precha, Hasber Salim

Abstract read
In one paragraph

Article in PloS one, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Abdul Rahim IsnainCentre of Environmental Health & Safety studies, Faculty of Health Sciences, Universiti Teknologi MARA (UiTM), UITM Cawangan Selangor, Puncak Alam, Selangor, Malaysia.
Nazri Che DomCentre of Environmental Health & Safety studies, Faculty of Health Sciences, Universiti Teknologi MARA (UiTM), UITM Cawangan Selangor, Puncak Alam, Selangor, Malaysia.ORCID 0000-0002-9882-3501
Samsuri AbdullahFaculty of Ocean Engineering Technology and Informatics, Universiti Malaysia Terengganu, Kuala Nerus, Terengganu, Malaysia.
Nopadol PrechaDepartment of Environmental Health and Technology, School of Public Health, Walailak University, Nakhon Si Thammarat, Thailand.
Hasber SalimSchool of Biological Sciences, Universiti Sains Malaysia, Minden Penang, Malaysia.ORCID 0000-0002-3550-2989

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionMany developing countries have drastically imbalanced health systems in different regions. The COVID-19 outbreak posed a further challenge as hospital structures, equipped with doctors, critical care units and respirators, were not available to a sufficient extent in all regions.

objectiveThis study is a descriptive study on the efficiency of Malaysian states in facing the COVID-19 outbreak. METHODOLOGY: The efficiency of all Malaysian states was measured using Data Envelopment Analysis in which each state's Score of COVID Index (SCI) was quantified. The SCI of these states were then further compared between the year 2020 and 2021. A greater disparity would indicate a decline in the performance of a state over time, where nearly all the states in Malaysia experienced an increase in the score of COVID Index (SCI).

resultThis study found that the central region was the most affected, since all the three states in the region (Selangor, Federal Territory of Kuala Lumpur, and Federal Territory of Putrajaya) showed a situation of inadequacy (SCI: >0.75) due to the COVID-19 outbreak.

conclusionThe ranking of Malaysia's states according to their vulnerability to an outbreak of COVID-19 is vitally significant for the purposes of assisting the government and policymakers in planning their responses to the outbreak and ensuring that resources are distributed appropriately.

Indexed as

COVID-19Disease OutbreaksHumansMalaysia

Identifiers

PMID36288385
PMCPMC9605290

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.